Showing results (71-80 of 118) with videos related to
Sort By:
Pageof 12
Addiction Biology|June 26, 2010
Chronic dopaminergic signaling in the basal ganglia: a damage perspective on kinases and fos-related antigensJ P O'Callaghan, D B Miller, K R PennypackerProstaglandins|July 1, 1987
Effects of E2 levuglandins on the contractile activity of the rat uterusD Foreman, L Zuk, D B Miller, et al.Analytical Biochemistry|October 21, 1999
Quantitative immunoblots of proteins resolved from brain homogenates: underestimation of specific protein concentration and of treatment effectsJ P O'Callaghan, H Imai, D B Miller, et al.Brain Research|March 4, 2000
Comparative study of fluoxetine, sibutramine, sertraline and dexfenfluramine on the morphology of serotonergic nerve terminals using serotonin immunohistochemistryM Kalia, J P O'Callaghan, D B Miller, et al.The Annals of Occupational Hygiene|September 4, 2008
A framework for the concurrent consideration of occupational hazards and obesityP A Schulte, G R Wagner, A Downes, et al.The Journal of Urology|June 1, 1982
Circadian and day-to-day variation of prostatic acid phosphataseI Nissenkorn, D D Mickey, D B Miller, et al.Toxicology|September 1, 1988
Developmental effects of maternal stress in the CD-1 mouse induced by restraint on single days during the period of major organogenesisN Chernoff, D B Miller, M B Rosen, et al.Prostaglandins|January 1, 1988
Anhydrolevuglandin D2 inhibits the uterotonic activity of prostaglandins F2 alpha and D2D Foreman, B S Levison, D B Miller, et al.Neuroscience|November 28, 2002
Obesity exacerbates chemically induced neurodegenerationK Sriram, S A Benkovic, D B Miller, et al.Journal of Neurochemistry|August 11, 1991
Diethyldithiocarbamate potentiates the neurotoxicity of in vivo 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine and of in vitro 1-methyl-4-phenylpyridiniumD B Miller, J F Reinhard, A J Daniels, et al.Pageof 12